Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

2.

Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

Dix BR, Edwards SJ, Braithwaite AW.

J Virol. 2001 Jun;75(12):5443-7. Review. No abstract available.

3.

Regulation of p53 protein function through alterations in protein-folding pathways.

Hupp TR.

Cell Mol Life Sci. 1999 Jan;55(1):88-95. Review.

PMID:
10065154
4.

Trp/Met/Phe hot spots in protein-protein interactions: potential targets in drug design.

Ma B, Nussinov R.

Curr Top Med Chem. 2007;7(10):999-1005. Review.

PMID:
17508933
5.

Aggregation prone regions and gatekeeping residues in protein sequences.

Beerten J, Schymkowitz J, Rousseau F.

Curr Top Med Chem. 2012;12(22):2470-8. Review.

PMID:
23339301
6.

The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Laptenko O, Tong DR, Manfredi J, Prives C.

Trends Biochem Sci. 2016 Dec;41(12):1022-1034. doi: 10.1016/j.tibs.2016.08.011. Review.

PMID:
27669647
Items per page

Supplemental Content

Support Center